Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Harvey Yu-Li Su"'
Autor:
Hui-Shan Huang, Harvey Yu-Li Su, Pei-Hsu Li, Po-Hui Chiang, Cheng-Hua Huang, Chien-Hsu Chen, Meng-Che Hsieh
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-7 (2018)
Abstract The impact of tumor infiltrating lymphocytes (TILs) on survival was confirmed in various cancer types. Our study aims to investigate the prognostic role of TILs on survival in patients with metastatic urothelial carcinoma (mUC) receiving pla
Externí odkaz:
https://doaj.org/article/0115a41fc34e4ccb9ec9539b02e5dec2
Autor:
Harvey Yu-Li Su, Ling-Yi Xiao, Shih-Yu Huang, Li-Chung Chang, Yi-Hua Chen, Hao-Lun Luo, Chia-Ling Wu
Publikováno v:
Cancer Research. 83:954-954
Background: Immune checkpoint inhibitor (ICI) has been widely used for advanced urothelial carcinoma (mUC) globally. However, little is known about the potential predictive factors of the ICI response. The study aims to identify a potential biomarker
Autor:
Chia Che Wu, Meng Che Hsieh, Cheng-Hua Huang, Shih Yu Huang, Harvey Yu-Li Su, Po Hui Chiang, Chun-Chieh Huang, Kun Ming Rau, Jui Ming Liu, Hao Lun Luo, Ming Tse Sung
Publikováno v:
Oncology. 98:146-153
Objectives: Platinum-based chemotherapy is the standard treatment for metastatic urothelial carcinoma (mUC). However, considering elderly patients often experience comorbidities and frailty, the utility of cisplatin-based chemotherapy for elderly pat
Publikováno v:
The American journal of gastroenterology. 115(11)
Autor:
Kun-Ming Rau, Meng-Che Hsieh, Chun-Chieh Huang, Po-Hui Chiang, Cheng-Hua Huang, Jui Lan, Hao-Lun Luo, Ming-Tse Sung, Harvey Yu-Li Su
Publikováno v:
Journal of Cancer
Background: Prognostic nutritional index (PNI) has been studied in various types of cancer which is significantly correlated with prognosis. The study aims to investigate the predictive role of PNI in patients with metastatic urothelial carcinoma (mU
Autor:
Harvey Yu-Li Su
Publikováno v:
Clinical Genitourinary Cancer. 16:114-116
Autor:
Jia-Sin Liu, Chia Che Wu, Yen-Yang Chen, Meng-Che Hsieh, Wei-Chieh Lee, Harvey Yu-Li Su, Kun-Ming Rau
Publikováno v:
Journal of Clinical Medicine, Vol 8, Iss 7, p 1024 (2019)
Journal of Clinical Medicine
Volume 8
Issue 7
Journal of Clinical Medicine
Volume 8
Issue 7
The emergence of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) caused a paradigm shift in the treatment of non-small cell lung cancer (NSCLC). Although several clinicopathologic factors to predict the response to and survival
Publikováno v:
Journal of Cancer Research and Practice. 7:111
Background: Thymic carcinoma (TC) is a rare but aggressive thymic epithelial neoplasm, with lymphoepithelioma-like histological features resembling nasopharyngeal carcinoma. Epstein–Barr virus is a known etiology of various tumors, including nasoph
Autor:
Harvey Yu-Li Su, Pei-Hsu Li, Cheng-Hua Huang, Meng-Che Hsieh, Hui-Shan Huang, Chien-Hsu Chen, Po-Hui Chiang
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-7 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-7 (2018)
The impact of tumor infiltrating lymphocytes (TILs) on survival was confirmed in various cancer types. Our study aims to investigate the prognostic role of TILs on survival in patients with metastatic urothelial carcinoma (mUC) receiving platinum bas